Literature DB >> 31020119

Malaise and fatigue following mitral valve repair: case report.

Lena Hinrichs1, Tienush Rassaf1, Matthias Totzeck1.   

Abstract

INTRODUCTION: Mitral valve regurgitation is the second most common valvular heart disease. In primary, degenerative mitral regurgitation (MR), valve repair is the preferred treatment option. CASE
PRESENTATION: We present a case of a 73-year-old man who was admitted to our cardiology department with progressively worsening shortness of breath (New York Heart Association-Classification IV) and fatigue 2 months after surgical mitral valve repair for MR. Transthoracic and transoesophageal echocardiography showed a remaining severe MR and mitral valve stenosis II°. Laboratory results showed an extra-corpuscular, mechanical, and haemolytic anaemia. After exclusion of other causes of haemolytic anaemia and the lack of clinical and laboratory improvement, the patient underwent valve replacement with a biological valve. Haemolysis parameter normalized and the clinical status improved. DISCUSSION: Although haemolysis after mechanical prosthetic mitral valve replacement is frequently recognized, haemolytic anaemia after mitral valve reconstruction is still an underestimated complication, and there are only a small number of reported cases. This case demonstrates the clinical diagnostic steps for excluding other causes of haemolytic anaemia after mitral valve repair in patients with a history of heart surgery.

Entities:  

Keywords:  Annuloplasty; Case report; Haemolysis; Mitral regurgitation; Mitral valve repair

Year:  2018        PMID: 31020119      PMCID: PMC6177080          DOI: 10.1093/ehjcr/yty039

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Learning points

It is important to include the diagnosis of haemolytic anaemia after mitral valve repair in patients with a history of heart surgery. Mechanical haemolysis rarely resolves spontaneously. In most valvular cases, patients will have to undergo valve replacement.

Introduction

Haemolysis after prosthetic mitral valve replacement is frequently recognized, but represents a rare complication following mitral valve repair. In this case report, we describe a patient who developed severe mechanical haemolysis 2 month after mitral valve repair.

Case presentation

A 73-year-old man was admitted to our cardiology department with progressively worsening shortness of breath (New York Heart Association-Classification IV) and fatigue 2 months after surgical mitral valve repair for mitral regurgitation (MR). His recovery had been prolonged due to a haemothorax requiring re-thoracotomy in combination with severe enterococcal sepsis treated with Vancomycin for 2 weeks and a right frontal watershed stroke with a residual paresis of the left arm. The patient’s medical history was significant for hypertension, atrial fibrillation, and coronary artery disease, for which he had undergone coronary artery bypass graft surgery in the context of mitral valve repair in November 2016.

Timeline

Upon arrival, he had pale conjunctivae and a holosystolic 3/6 apical murmur radiating to the axilla. Mild bibasilar crackles were audible, and there were bilateral lower extremity oedema. Blood pressure was 130/80 mmHg, heart rate was 80 beats per minute, temperature was 36.6°C, and chest X-ray showed a slight pleural effusion of the left lung without infiltrates. The patient’s blood test showed haemoglobin and haptoglobin reduced and lactate dehydrogenase increased as hallmarks of an intravascular extracorpuscular anaemia (Table ). The haemoglobin level was 6.6 g/day (normal range 13.6–17.2 g/dL), haematocrit was 0.20 (normal range 0.39–0.49), and reticulocyte count was elevated. Haptoglobin was reduced to 0.01 g/dL (normal range 0.5–2.4 g/dL), total bilirubin was 1.4 mg/dL (normal range 0.3–1.2 mg/dL) with an indirect hyperbilirubin of 0.4 mg/dL (normal range <0.2 mg/dL), and lactate dehydrogenase level were elevated to 1382 units per litre (normal range 100–247 units per litre). Brain natriuretic peptide levels were increased to 374.2 pg/mL (normal range <100 pg/mL). Creatinine and cardiac enzyme levels were within normal limits. Given that mechanical haemolysis is rarely observed in patients treated with valve repair, it was essential to exclude other potential causes of haemolysis. The most important differential diagnosis was autoimmune haemolytic anaemia with antibodies against erythrocyte structural components. Autoimmune haemolytic anaemia may develop after severe infections or post-surgery. To exclude autoimmune haemolytic anaemia, a coombs test was performed as well as a specific coombs test and cold agglutination, which were negative, thus supporting the diagnosis of surgery related haemolysis.
TimeEvents
Day 1Mitral valve repair due to mitral valve prolapse and severe mitral regurgitation insufficiency in conjunction with coronary artery bypass graft surgery
1 weekHaemothorax requiring re-thoracotomy
3 weeksSevere enterococcal sepsis and right frontal watershed stroke
1.5 monthsTransfer to a rehabilitation clinic
2 monthsPatient presented with progressively worsening shortness of breath (New York Heart Association-Classification IV) and fatigue Laboratory results showed an extra-corpuscular haemolytic anaemia.
2–5 monthsPatient developed recurrent transfusion-requiring conditions
5 monthsRe-operation with mitral valve replacement and tricuspidal repair with annuloplasty ring implantation
6 monthsHaemolysis parameters normalized and the clinical status improved
Laboratory parameters Transthoracic and transoesophageal echocardiography revealed a high-grade mitral valve regurgitation and mitral valve stenosis II° (Figure , Supplementary material online, Videos S1 and S2). Mean pressure gradient was 7 mmHg with an eccentric jet. Pulmonary hypertension and second degree tricuspid valve regurgitation were detected. (A, B) 2D and 3D transoesophageal echocardiography showed incomplete repair after mitral valve surgery with an eccentric jet (arrow). (C) Post-operative transoesophageal echocardiography with a good result after mitral valve replacement without regurgitation. The patient developed recurrent transfusion-requiring conditions. At four occasions, a total of eight erythrocyte concentrates were transfused. After reaching a satisfactory general state of health, the patient was referred to valve replacement with a 27 mm biological prosthesis (Sorin Pericarbon) and tricuspidal repair with annuloplasty ring implantation (30 mm Contour 3D Medtronic). The histopathological examination revealed a myxoid mitral valve degeneration. Haemolysis parameters normalized and the clinical status improved quickly. Within 3 months, all parameters were within normal ranges. Upon his most recent follow-up visitation, 9 month after valve replacement, the patient reported a significantly improved exercise capacity. Control echocardiography showed a good result after mitral valve replacement without residual regurgitation (Figure ).

Discussion

Mitral regurgitation is the second most common valvular heart disease and can be subdivided in a primary, degenerative form and a secondary mitral valve regurgitation due to ischaemia and dilatation., In primary MR, valve repair is the preferred treatment option. Valve repair provides lower impairment of the left ventricular heart function, lower complication rates, and operative mortality, better long-term results and, no need for anticoagulation. The surgical steps include annuloplasty, shortening of tendinous chords in combination with prolapse and leaflet resection., Patients developing haemolysis after mitral valve repair generally present within the first 2–6 months after surgery. Possible mechanisms of haemolysis after valvular repair are fragmentation of the regurgitant jet by a annuloplasty ring dehiscence, collision of the regurgitant jet into the prosthetic ring, and rapid acceleration of a jet through a small para-ring leakage. The regurgitant jet itself perpetuates haemolysis by delaying endothelialization of the valvuloplasty ring, leading to further fragmentation and collision. In approximately 35% of all patients, haemolysis is caused by incomplete initial repair or technical error and has been described even in cases of mild MR. Timely echocardiographic evaluation is important to diagnose the pathology and may lead to re-repair or replacement of the valve. Guideline recommendations concerning the treatment of haemolysis after mitral valve repair are currently not available, but mechanical haemolysis rarely resolves spontaneously. In most cases, patients will have to undergo valve replacement. This clinical case shows the importance of including the diagnosis of haemolytic anaemia after mitral valve repair in patients with a history of heart surgery.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: none declared. Click here for additional data file.
Table 1

Laboratory parameters

Laboratory parametersObserved valuesReverence range
Haemoglobin6.6 g/dL13.6–17.2 g/dL
Haematocrit0.20.39–0.49
Reticulocytes5%0.5–2%
FragmentocytesPositiveNegative
Haptoglobin0.01 g/L0.5–2.4 g/L
Total bilirubin1.4 mg/dL0.3-1.2 mg/dL
Indirect bilirubin0.4 mg/dL<0.2 mg/dL
Lactate dehydrogenase1382 U/L100–247 U/L
Brain natriuretic peptide347.2 pg/mL<100 pg/mL
C-reactive protein<0.05 mg/dL<0.05 mg/dL
White blood cells8.46 × 109/L4–10 × 109/L
Specific coombs testNegativeNegative
Cold agglutinationNegativeNegative
  10 in total

Review 1.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

2.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

3.  Burden of valvular heart diseases: a population-based study.

Authors:  Vuyisile T Nkomo; Julius M Gardin; Thomas N Skelton; John S Gottdiener; Christopher G Scott; Maurice Enriquez-Sarano
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

4.  Hemolytic anemia following mitral valve repair: A case presentation and literature review.

Authors:  Georges Abourjaili; Estelle Torbey; Taher Alsaghir; Yefim Olkovski; Thomas Costantino
Journal:  Exp Clin Cardiol       Date:  2012

5.  Hemolysis after mitral valve repair: mechanisms and treatment.

Authors:  Buu Khanh Lam; Delos M Cosgrove; Sunil K Bhudia; A Marc Gillinov
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

6.  Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.

Authors:  James S Gammie; Shubin Sheng; Bartley P Griffith; Eric D Peterson; J Scott Rankin; Sean M O'Brien; James M Brown
Journal:  Ann Thorac Surg       Date:  2009-05       Impact factor: 4.330

7.  Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation.

Authors:  M J Garcia; P Vandervoort; W J Stewart; B W Lytle; D M Cosgrove; J D Thomas; B P Griffin
Journal:  J Am Coll Cardiol       Date:  1996-02       Impact factor: 24.094

8.  Mechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography.

Authors:  T C Yeo; W K Freeman; H V Schaff; T A Orszulak
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

9.  Valve repair versus valve replacement for degenerative mitral valve disease.

Authors:  A Marc Gillinov; Eugene H Blackstone; Edward R Nowicki; Worawong Slisatkorn; Ghannam Al-Dossari; Douglas R Johnston; Kristopher M George; Penny L Houghtaling; Brian Griffin; Joseph F Sabik; Lars G Svensson
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03-04       Impact factor: 5.209

10.  Mitral valve repair: the chordae tendineae.

Authors:  Carlos-A Mestres; José M Bernal
Journal:  J Tehran Heart Cent       Date:  2012-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.